EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Thymoma‐associated autoimmune encephalitis: Analysis of factors determining prognosis

Wenli Song, Keru Li, Jiao Li, Xiaoni Liu, Xiaoke Wu, Xiaodong Xu, Kangping Xiong, Xiangjun Chen iD, Yanlin Zhang iD

CNS Neuroscience & Therapeutics · 2023-05 · 29 (5) · 1213-1221

DOI: 10.1111/cns.14166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 13.03.2023. Verfasst von Wenli Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms, Autoimmune Diseases of the Nervous System. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Autoimmune encephalitis (AE) is a heterogeneous group of inflammatory central nervous system disorders caused by a misdirected immune response against self‐antigens expressed in the central nervous system. The thymus is a central organ in the immune system and thymic tumors are thought to be possible initiators of many neurological disorders. Recently, there is growing evidence that thymomas are associated with autoimmune encephalitis.

Aims

Our study initially explored the characteristics of patients with autoimmune encephalitis combined with thymoma.

Methods

We used patient data from January 1, 2011 to October 1, 2021 from the PubMed, Web of Science, Ovid, and CNKI platforms to analyze overall demographics, frequency of symptoms and associations, and treatment prognosis outcomes.

Results

A total of 68 patients were included. There were 39 female cases (57.4%). The mean age was 50 years (IQR 40–66 years). All had acute and subacute onset. The clinical manifestations were mostly cognitive changes (70.6%), mental disorders (57.4%), and epilepsy (50.0%). The most common neuronal antibody was alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA). Magnetic resonance imaging (MRI) abnormalities were present in 81.0% of patients, mostly in the hippocampus, temporal lobe, and some in cortical and subcortical areas. Abnormalities in the electroencephalogram (EEG) in 69.8% of patients. Treatment involved immunotherapy and thymoma treatment, with 79.7% of patients improving after treatment. While 20.3% of patients had a poor prognosis. Further, 14.8% of patients relapsed. Mental disorders, autonomic dysfunction, sleep disturbances, anti‐Ma2, and thymoma untreated were more frequent in patients with poor prognosis.

Conclusion

Thymoma‐associated autoimmune encephalitis is a unique disease entity. Long‐term follow‐up of chest CT findings is recommended for patients with autoimmune encephalitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymomaThymus NeoplasmsAutoimmune Diseases of the Nervous SystemPrognosisFemaleMiddle AgedHashimoto DiseaseEncephalitisHumansAutoantibodies

Stichwörter der Autor:innen

autoimmune encephalitisimmune disordersprognosisthymomatreatment

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Neurology, Huashan Hospital and Institute of Neurology, Fudan University, Shanghai, China.
  • National Center for Neurological Disorders, Fudan University, Shanghai, China.
  • Human Phenome Institute, Fudan University, Shanghai, China.

ORCID-Profile: Xiangjun Chen, Yanlin Zhang

Zitieren

APA

Song, W., Li, K., Li, J., Liu, X., Wu, X., Xu, X., Xiong, K., Chen, X., & Zhang, Y. (2023). Thymoma‐associated autoimmune encephalitis: Analysis of factors determining prognosis. CNS Neuroscience & Therapeutics, 29(5), 1213-1221. https://doi.org/10.1111/cns.14166

Vancouver

Song W, Li K, Li J, Liu X, Wu X, Xu X, et al. Thymoma‐associated autoimmune encephalitis: Analysis of factors determining prognosis. CNS Neuroscience & Therapeutics. 2023;29(5):1213-1221. doi:10.1111/cns.14166

BibTeX
@article{Song2023,
  author = {Song, Wenli and Li, Keru and Li, Jiao and Liu, Xiaoni and Wu, Xiaoke and Xu, Xiaodong and Xiong, Kangping and Chen, Xiangjun and Zhang, Yanlin},
  title = {Thymoma‐associated autoimmune encephalitis: Analysis of factors determining prognosis},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2023},
  volume = {29},
  number = {5},
  pages = {1213--1221},
  doi = {10.1111/cns.14166}
}
Kostenlos starten →